Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens

E-ISSN： 1873-5576|18|2|162-170

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.2, 2018-01, pp. : 162-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chimeric Herpes Simplex Virus/Adeno-Associated Virus Amplicon Vectors

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 315-324

Bentham Science Publishers

Access to resources Recommend Favorite

Host responses to herpes simplex virus and herpes simplex virus vectors

By Hukkanen Veijo Paavilainen Henrik Mattila Riikka K

Future Virology, Vol. 5, Iss. 4, 2010-07 ,pp. : 493-512

Future Medicine

Access to resources Recommend Favorite

Herpes Simplex Virus Vectors for the Nervous System

Current Gene Therapy, Vol. 1, Iss. 4, 2001-11 ,pp. : 339-358

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Replicating herpes simplex virus vectors for cancer gene therapy

By Yeung S.N. Tufaro F.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite